14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

CASI Pharmaceuticals Stock Forecast

NASDAQ:CASI BUY SELL

$0.36 (3.96%)

Volume: 477.395k

Closed: May 16, 2022

Hollow Logo Score: -2.450

CASI Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:CASI
$0.36 (3.96%)

Volume: 477.395k

Closed: May 16, 2022

Score Hollow Logo -2.450

CASI Pharmaceuticals Stock Forecast NASDAQ:CASI

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-16 733.33% HC Wainwright & Co. $4.00 $3.00 Maintains Buy
2021-05-18 1011.11% BTIG $4.00 Initiates Coverage On Buy
2021-05-14 1011.11% HC Wainwright & Co. $3.50 $4.00 Maintains Buy
2021-04-26 955.56% Mizuho $3.80 Initiates Coverage On Buy
2020-10-23 1288.89% Oppenheimer $5.00 Initiates Coverage On Outperform
2020-03-24 872.22% HC Wainwright & Co. $7.00 $3.50 Maintains Buy

CASI Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -50.11% during the next 3 months and, with a 90% probability hold a price between $0.15 and $0.30 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-18 $0.28 $0.44 $0.59
2022-05-19 $0.27 $0.43 $0.58
2022-05-20 $0.26 $0.42 $0.57
2022-05-23 $0.25 $0.41 $0.56
2022-05-24 $0.24 $0.40 $0.55
2022-05-25 $0.23 $0.39 $0.54
2022-05-26 $0.22 $0.38 $0.53
2022-05-27 $0.21 $0.37 $0.52
2022-05-31 $0.20 $0.36 $0.51
2022-06-01 $0.19 $0.35 $0.50
2022-06-02 $0.18 $0.34 $0.49
2022-06-03 $0.17 $0.33 $0.48
2022-06-06 $0.16 $0.32 $0.47
2022-06-07 $0.15 $0.31 $0.46
2022-06-08 $0.14 $0.30 $0.45
2022-06-09 $0.13 $0.29 $0.44
2022-06-10 $0.12 $0.28 $0.43
2022-06-13 $0.11 $0.27 $0.42
2022-06-14 $0.10 $0.26 $0.41
2022-06-15 $0.0915 $0.25 $0.40
2022-06-16 $0.0815 $0.23 $0.39
2022-06-17 $0.0714 $0.22 $0.38
2022-06-21 $0.0614 $0.21 $0.37
2022-06-22 $0.0514 $0.20 $0.36
2022-06-23 $0.0414 $0.19 $0.35
2022-06-24 $0.0313 $0.18 $0.34
2022-06-27 $0.0213 $0.17 $0.33
2022-06-28 $0.0113 $0.16 $0.32
2022-06-29 $0.0013 $0.15 $0.31
2022-06-30 $-0.0088 $0.14 $0.30

About CASI Pharmaceuticals

CASI Pharmaceuticals CASI Pharmaceuticals, Inc., a late-stage biopharmaceutical company, acquires, develops, and commercializes therapeutics addressing cancer and other unmet medical needs in China. Its lead drug candidate is ENMD-2076, an Aurora A and angiogenic kinase inhibitor, which is in multiple Phase II studies in advanced fibrolamellar carcinoma, triple-negative breast cancer, advanced ovarian clear cell carcinomas, and advanced/metastatic soft tissue sarcoma... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT